Trial Profile
Phase II trial of leronlimab for stroke
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2020
Price :
$35
*
At a glance
- Drugs Leronlimab (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors CytoDyn
- 30 Oct 2020 New trial record
- 26 Oct 2020 According to a CytoDyn media release, the company is accelerating the filing of a protocol and IND for this study.